share_log

传奇生物(LEGN.US)预计上半年调整后净亏损至多1.1亿美元

Legend biotech (LEGN.US) is expected to have a net loss of up to 0.11 billion US dollars in the first half of the year after adjustment.

Zhitong Finance ·  Jul 26 21:31

Legend biotech (LEGN.US) is expected to have a net loss of approximately $94.7 million to $0.1097 billion after adjustment in the first half of 2024.

According to the Zhitongcaijing APP, Legend biotech (LEGN.US) is expected to have a net loss of approximately $94.7 million to $0.1097 billion after adjustment in the first half of 2024. The company also expects a net loss of $75.4 million to $87.4 million in the first half of 2024.

Legend biotech will release its six-month financial report ending on June 30, 2024 on August 9.

As of press time, Legend biotech fell nearly 1% at the beginning of the session.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment